References
H. Raff, S.B. Magill, Is the hypothalamic—pituitary—adrenal axis disrupted in type 2 diabetes mellitus? Endocrine 54(1), 273–275 (2016)
E.K. Spanakis, X. Wang, B.N. Sanchez, A.V. Diez Roux, B.L. Needham, G.S. Wand, T. Seeman, S.H. Golden, Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis. Endocrine 53(1), 227–239 (2016)
G. Bellastella, M.I. Maiorino, A. De Bellis, M.T. Vietri, C. Mosca, L. Scappaticcio, D. Pasquali, K. Esposito, D. Giugliano, Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes. Endocrine 53(1), 220–226 (2016)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no competing interests.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Rights and permissions
About this article
Cite this article
Eller-Vainicher, C., Scillitani, A. & Chiodini, I. Is the hypothalamic–pituitary–adrenal axis disrupted in type 2 diabetes mellitus and is this relevant for bone health?. Endocrine 58, 201–202 (2017). https://doi.org/10.1007/s12020-017-1237-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1237-1